Episode Details

Back to Episodes
Episode 154: ASCO GU 2022 MAGNITUDE trial of niraparib and abiraterone in metastatic CRPC

Episode 154: ASCO GU 2022 MAGNITUDE trial of niraparib and abiraterone in metastatic CRPC

Season 1 Episode 154 Published 4 years, 8 months ago
Description
Kim Chi describes the results of this randomised phase 3 study.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us